These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1803779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deadly Marburg virus: scientists race to test vaccines in outbreak.
    Callaway E.
    Nature; 2024 Oct; 634(8033):278. PubMed ID: 39354138
    [No Abstract] [Full Text] [Related]

  • 9. A single shot against Ebola and Marburg virus.
    Baize S.
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract] [Full Text] [Related]

  • 10. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
    Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A.
    Virology; 1998 Nov 10; 251(1):28-37. PubMed ID: 9813200
    [Abstract] [Full Text] [Related]

  • 11. Good news for Marburg virus workers.
    Becker S.
    Lancet; 2006 Apr 29; 367(9520):1373-4. PubMed ID: 16650630
    [No Abstract] [Full Text] [Related]

  • 12. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
    Wang D, Hevey M, Juompan LY, Trubey CM, Raja NU, Deitz SB, Woraratanadharm J, Luo M, Yu H, Swain BM, Moore KM, Dong JY.
    Virology; 2006 Sep 30; 353(2):324-32. PubMed ID: 16820184
    [Abstract] [Full Text] [Related]

  • 13. [Design of equine serum-based Marburg virus immunoglobulin].
    Borisevich IV, Potryvaeva NV, Mel'nikov SA, Evseev AA, Krasnianskiĭ VP, Maksimov VA.
    Vopr Virusol; 2008 Sep 30; 53(1):39-41. PubMed ID: 18318136
    [Abstract] [Full Text] [Related]

  • 14. [The immunogenic properties of Marburg virus proteins].
    Agafonov AP, Ignat'ev GM, Kuz'min VA, Akimenko ZL, Kosareva TV, Kashentseva EA.
    Vopr Virusol; 1992 Sep 30; 37(1):58-61. PubMed ID: 1413715
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms of protective immune response in models of Marburg fever in monkeys].
    Ignat'ev GM, Strel'tsova MA, Agafonov AP, Kashentseva EA.
    Vopr Virusol; 1995 Sep 30; 40(3):109-13. PubMed ID: 7676670
    [Abstract] [Full Text] [Related]

  • 16. [A trial to produce an inactivated Lassa fever vaccine].
    Krasnianskiĭ VP, Potryvaeva NV, Borisevich IV, Gradoboev VN, Pashanina TP, Pshenichnov VA.
    Vopr Virusol; 1993 Sep 30; 38(6):276-9. PubMed ID: 8303891
    [Abstract] [Full Text] [Related]

  • 17. Postexposure treatment of Marburg virus infection.
    Geisbert TW, Hensley LE, Geisbert JB, Leung A, Johnson JC, Grolla A, Feldmann H.
    Emerg Infect Dis; 2010 Jul 30; 16(7):1119-22. PubMed ID: 20587184
    [Abstract] [Full Text] [Related]

  • 18. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
    Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deitz SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY.
    Vaccine; 2006 Apr 05; 24(15):2975-86. PubMed ID: 16530297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.